This is written like they are disrupting the model, but in reality GoodRx is just another pharmacy in the old model. Operating exactly the same way of taking ki

This is written like they are disrupting the model, but in reality GoodRx is just another pharmacy in the old model. Operating exactly the same way of taking kickbacks from PBMs who in turn raid the drug producers while driving price hikes most often eating up well above 50% of those price hikes themselves. Seems the only difference is “it’s a tech company” which changes their valuation and ability to raise capital, but they still don’t seem to actually be disrupting anything, just another cog in the broken machine. Or am I missing something?